The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Drug overdose deaths rose during the early part of the COVID-19 pandemic, with some of the biggest jumps occurring among people of color. This analysis breaks out drug overdose deaths by race and ethnicity for the first nine months of 2020, to the same period in each of the two prior years. It also looks at access to care issues and recent and pending legislation aimed at addressing the nation’s substance use and mental health…
We reviewed the websites and other official state sources for all 50 states and D.C. to see which are providing data on COVID-19 breakthrough cases, hospitalizations and deaths, how regularly, and what those data may tell us.
Analysis of characteristics of children under 12 in the U.S. to help inform COVID-19 vaccination efforts when they become eligible.
On June 23, 2021, a circuit court decision in Missouri put the state’s expansion of Medicaid under the Affordable Care Act (ACA) in limbo. This decision, if upheld, has implications for coverage in the state as well as the availability of federal financing to cover the cost.
This post looks at a new contactless method of providing medication abortions and now this can be and has been used in response to the pandemic. The post also examines state policies that act as barriers to implementing these new protocols.
Updated Data on State Parental Consent Laws for COVID-19 Vaccination Available Here. With the recent authorization of Pfizer’s COVID-19 vaccine for adolescents, ages 12-15, a group that totals almost 17 million, the next phase of the U.S. vaccination effort has begun. Authorization for even younger children is expected as early as the fall, and even before this point, Pfizer’s vaccine had been authorized for 16-17 year-olds. This has focused attention on the role of parents…
While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country. In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.
Although attention in current federal actions is largely focused on Medicare and private insurance drug prices, federal legislation also has been recently introduced or enacted that would affect Medicaid prescription drug policy.
Providing paid time off to employees to get and recover from any side effects could help boost vaccination rates. Overall, nearly three in ten (28%) employed adults who not yet ready to get the vaccine say that they would be more likely to get the COVID-19 vaccine if their employer gave them paid time off to get vaccinated and recover from any side effects.
This post examines characteristics of adolescents ages 12 to 15 across in the United States to inform COVID-19 vaccination efforts once they become eligible to receive a vaccine.
© 2026 KFF